Concepedia

Leigh Marcus

LM

17

Publications

3.1K

Citations

16

H-Index

2011

Active since

Affiliations

National Institutes of Health(Current)

Center for Drug Evaluation and Research

United States Food and Drug Administration

National Cancer Institute

Children's National

Leigh Marcus is an author at National Institutes of Health specializing in oncology, cancer therapeutics, and cancer research.

ORCID

Top concepts

Publications per year

2011–2022

17

Publications

17

FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors

Leigh Marcus, Steven J. Lemery, Patricia Keegan et al. · Clinical Cancer Research · 2019 · 1.1K citations

, , +13

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

Eva Dombi, Andrea Baldwin, Leigh Marcus et al. · New England Journal of Medicine · 2016 · 639 citations · Full text

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors

Leigh Marcus, Lola A. Fashoyin‐Aje, Martha Donoghue et al. · Clinical Cancer Research · 2021 · 532 citations · Full text

FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma

Sandra J. Casak, Leigh Marcus, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2021 · 167 citations · Full text

Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma

Elizabeth Fox, Brigitte C. Widemann, Meredith K. Chuk et al. · Clinical Cancer Research · 2013 · 153 citations · Full text

Rows per page

1–5 of 17